BioHealth Analyst Cautious/Negative Calls (BIIB, ESRX, GENZ, MHS, SGEN)

June 19, 2008 · Filed Under General 

These are some of the downgrades and negative or cautious calls being seen in the biotech and medical-health sectors this Thursday morning:

  • Biogen-IDEC (NASDAQ: BIIB) Started as Hold at Deutsche Bank.
  • Express Scripts (NASDAQ: ESRX) Cut to Neutral from Buy at UBS.
  • Genzyme (NASDAQ: GENZ) Started As Hold at Deutsche Bank.
  • Medco Health Solutions (NYSE: MHS) cut to Neutral at UBS.
  • Seattle Genetics (NASDAQ: SGEN) Started as Neutral at UBS.

You can see the list of positive calls and upgrades here.

Jon Ogg
June 19, 2008

Tags: , , , , , ,

Comments

Comments are closed.

    Subscribe to BioHealth Investor BioHealth Investor RSS Feed